In this study, we constructed an immune-related prognostic signature based on four immune-related genes (ADA2, TLR1, PTPN6, and S100P) that displayed good predictive ability for overall survival and analyzed the infiltration of corresponding immune cells in patients with pancreatic cancer. This evidence concerns the gene ADA2 and familial pancreatic carcinoma.